Salmonella spondylodiscitis in patients without sickle cell disease.
The optimal treatment of salmonella spondylodiscitis is controversial. The cases of eight patients who had salmonella spondylitis without sickle cell disease were reviewed. Back pain (100%), fever (75%), and elevated C-reactive protein levels (100%) were common, but gastrointestinal symptoms were not (0%). Six patients had positive blood cultures, and the other two had positive tissue cultures. Group C1 salmonella was the most common serotype. Two patients with coexisting aortic mycotic aneurysms had immediate aneurysm resection. Three others responded favorably to appropriate antibiotics, and three required subsequent surgical reconstruction because of neurologic impairment or osseous instability. Clinical outcomes were significantly better than those of 46 previously reported patients. Salmonella spondylodiscitis usually responds favorably to appropriate antibiotics; consequently, a tissue diagnosis is important. Operative interventions are necessary only for patients with coexisting aneurysms or ongoing osseous instability. A ruptured aortic aneurysm with pseudoaneurysm may mimic a paravertebral abscess, and surgery at the site of an unsuspected aneurysm may precipitate life-threatening hemorrhage. Satisfactory results may be depend on early surgical intervention for a mycotic aneurysm and also are related to host immunity.
Chang
I-Chang
IC
Institute of Medicine, Chung-shan Medical University and Department of Orthopaedic Surgery, Chung-shan Medical University Hospital, Taichung, Taiwan. ic40249@ms34.hinet.net
D000328:Adult; D000368:Aged; D000755:Anemia, Sickle Cell / Q000150:complications; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001416:Back Pain / Q000209:etiology; D002097:C-Reactive Protein / Q000378:metabolism; D015299:Discitis / Q000150:complications / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy*; D005260:Female; D005334:Fever / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D012480:Salmonella Infections / Q000150:complications / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D002097:C-Reactive Protein